chr9-36249334-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001128227.3(GNE):c.115C>T(p.Arg39Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000239 in 1,461,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R39R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001128227.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GNE | NM_001128227.3 | c.115C>T | p.Arg39Ter | stop_gained | 2/12 | ENST00000396594.8 | |
GNE | NM_005476.7 | c.22C>T | p.Arg8Ter | stop_gained | 2/12 | ENST00000642385.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GNE | ENST00000396594.8 | c.115C>T | p.Arg39Ter | stop_gained | 2/12 | 1 | NM_001128227.3 | ||
GNE | ENST00000642385.2 | c.22C>T | p.Arg8Ter | stop_gained | 2/12 | NM_005476.7 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251278Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135822
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461606Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727102
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
GNE myopathy Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jul 24, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 07, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin | Sep 16, 2022 | - - |
Sialuria;C1853926:GNE myopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 18, 2023 | This sequence change creates a premature translational stop signal (p.Arg39*) in the GNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNE are known to be pathogenic (PMID: 24027297). This variant is present in population databases (rs766420673, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with autosomal recessive GNE-related myopathy (PMID: 20059379, 22507750). This variant is also known as p.Arg8*. ClinVar contains an entry for this variant (Variation ID: 552994). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at